These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16210395)

  • 21. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
    Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
    Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors.
    Brown L; Chefer S; Pavlova O; Vaupel DB; Koren AO; Kimes AS; Horti AG; Mukhin AG
    J Neurochem; 2004 Nov; 91(3):600-12. PubMed ID: 15485491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
    Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a computational approach to predict blood-brain barrier permeability.
    Liu X; Tu M; Kelly RS; Chen C; Smith BJ
    Drug Metab Dispos; 2004 Jan; 32(1):132-9. PubMed ID: 14709630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Positron Emission Tomography Radiotracers for the GABA Transporter 1.
    Sowa AR; Brooks AF; Shao X; Henderson BD; Sherman P; Arteaga J; Stauff J; Lee AC; Koeppe RA; Scott PJH; Kilbourn MR
    ACS Chem Neurosci; 2018 Nov; 9(11):2767-2773. PubMed ID: 29763549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Imaging blood-brain barrier function by using positron emission tomography to evaluate drug penetration into the brain].
    Takano H; Suhara T
    Brain Nerve; 2013 Feb; 65(2):137-43. PubMed ID: 23399671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
    Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
    J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors.
    Brown LL; Kulkarni S; Pavlova OA; Koren AO; Mukhin AG; Newman AH; Horti AG
    J Med Chem; 2002 Jun; 45(13):2841-9. PubMed ID: 12061886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.
    Elsinga PH; Hendrikse NH; Bart J; Vaalburg W; van Waarde A
    Curr Pharm Des; 2004; 10(13):1493-503. PubMed ID: 15134571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease.
    Schmaljohann J; Minnerop M; Karwath P; Gündisch D; Falkai P; Guhlke S; Wüllner U
    Appl Radiat Isot; 2004 Dec; 61(6):1235-40. PubMed ID: 15388115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model.
    Roux GL; Jarray R; Guyot AC; Pavoni S; Costa N; Théodoro F; Nassor F; Pruvost A; Tournier N; Kiyan Y; Langer O; Yates F; Deslys JP; Mabondzo A
    Sci Rep; 2019 Nov; 9(1):16310. PubMed ID: 31690750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
    Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics.
    Bergmann S; Lawler SE; Qu Y; Fadzen CM; Wolfe JM; Regan MS; Pentelute BL; Agar NYR; Cho CF
    Nat Protoc; 2018 Dec; 13(12):2827-2843. PubMed ID: 30382243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to measure drug transport across the blood-brain barrier.
    Bickel U
    NeuroRx; 2005 Jan; 2(1):15-26. PubMed ID: 15717054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
    Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
    Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Influence of Astrocytes on
    García-Salvador A; Domínguez-Monedero A; Gómez-Fernández P; García-Bilbao A; Carregal-Romero S; Castilla J; Goñi-de-Cerio F
    Altern Lab Anim; 2020 Jul; 48(4):184-200. PubMed ID: 33136430
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs.
    Neuhaus W; Mandikova J; Pawlowitsch R; Linz B; Bennani-Baiti B; Lauer R; Lachmann B; Noe CR
    Pharmazie; 2012 May; 67(5):432-9. PubMed ID: 22764578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
    Lu W; Tan YZ; Jiang XG
    Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.